Stock Ticker

  • Loading stock data...

FDA Approves Novartis Entresto As Treatment To Deal With More Heart Failure Complications

There is new hope for persons struggling with heart failure after the FDA approved Novartis Entresto. This therapy breaks the record for becoming the first to receive approval as a form of treatment for persons struggling with heart failure. The medication will targets persons struggling with both the preserved ejection fraction (HFpEF)(1-3) and reduced ejection […]